Clinical study of sufentanil balanced anesthesia combined with transversus abdominis plane block to promote postoperative recovery for elderly patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16007738

Enrollment

Unknown

Registered

2016-01-12

Start date

2016-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgical pain

Interventions

1:sufentanil0.05ng/ml

2:sufentanil0.25ng/ml

3:sufentanil0.5ng/ml

4:sufentanil+TAP

5:sufentanil+dexmedetomidine

Eligibility

Sex/Gender

All

Age

60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. To be aged 60 to 80 years; 2. ASA II ~ III; 3. undergoing surgery of liver cancer or colon cancer; 4. to be anesthetized by general anesthesia with endotracheal intubation or combined with transversus abdominis plane block; 5. to be approved by the subjects and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. existing diabetes, obvious electrolyte and acid-base balance disorders, diseases of the central nervous system, or serious diseases of liver or kidney, preoperatively; 2. history of alcohol or drug addiction; 3. intra-operative change of operation scheme or massive bleeding (3000ml above); 4. any other situation that should be excluded from this study.

Design outcomes

Primary

Measure	Time frame
postoperative recovery;	—

Secondary

Measure	Time frame
stress and pain;inflammatory factors;dosage of anesthetics;	—

Countries

China

Contacts

Public ContactHuang Hai-ming

heminghw@163.com+86 13922191091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026